| |
|
|
|
Arcus Biosciences Inc.  
|
|
9.05 0.77 (0.09%) |
06-17 16:02 |
|
Open: |
8.31 |
Pre close: |
8.28 |
Target:
|
11.07 
|
|
High: |
9.2 |
Low: |
8.28 |
Resistance:
|
9.48
10.76
|
|
Volume: |
1,489,884 |
Market Cap: |
414M |
Support:
|
7.40
6.16
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.39
 |
MACD |
MACD(12,26):
|
-0.46 |
|
MA(20): |
8.57 |
Signal(12,26,9): |
-0.61 |
|
MA(100): |
10.66 |
Stochastic Oscillator |
%K(14,3):
|
62.02 |
|
MA(250): |
11.54 |
%D(3): |
47.30 |
|
Average Volume(K) |
3-Month: |
13697
|
52-Week |
High:
|
17.18 |
|
10-Days: |
35534 |
Low: |
7.40 |
|
RSI |
RSI(14):
|
51.34 |
Change(%): |
-43.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.220 |
Return on Equity (ttm) |
-22.3 |
Shares Out. (M) |
44.54 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-19.3 |
Shares Float (M) |
43.90 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.40 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
40.0 |
% Held by Institutions |
47.40 |
|
Forward EPS |
-1.849 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
828 |
|
Book Value (p.s.) |
1.610 |
EBITDA (p.s.) |
0.000 |
P/E |
-4.08 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
5.62 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-46.59 |
P/S |
2071997568.00 |
|
Operating Margin |
-681.14 |
Levered Free Cash Flow
(M) |
-28.78 |
P/CF |
-8.65 |
|
|
|
|
|
|
